Dear Jiangxi Hongda Medical Equipment Group Ltd

With this letter I would like to provide information regarding the need for single-use
syringes (Auto Disable Syringes) in the Republic of Indonesia for the routine national
immunization program per year and Covid-19 vaccination where the need for ADS
syringes reaches 500 million pieces in 2022, for type 0.05, 0.3, 0.5, 3 and 5 ml.
Based on these needs, we kindly need support from Jiangxi Hongda Medical
Equipment Group Ltd can give PT. Hongda Indonesia rights as the sole representative
office in Indonesia, this is needed for the following processes/activities:

1. Permit to conduct business activities in Indonesia

2. Permission to appoint a manufacturer in Indonesia
3. Permit to import finished products/raw materials
4. Permission for TKDN certificate management
5. Establishment Representative office of PT. Hongda Indonesia in every legality
in the republic of Indonesia
When we have obtained permission from Jiangxi Hongda Medical Equipment Group
Ltd then the purchase transaction is through the PT. Hongda Indonesia.
Thank you for your kind understanding and cooperation, we look forward to building
a strong business relationship in the future.

Sincerely yours,

Leo